As pharmaceutical companies venture into global markets, the need for swift, precise, and efficient translation of pharmacovigilance (PV) documents has never been more pressing. This is where AI comes into play, revolutionizing PV translation with its transformative capabilities.

By combining AI technology with human expertise, companies can significantly enhance speed, reduce costs, and improve accuracy. In this blog, we highlight five key reasons why AI-driven PV translation is important for modern pharmaceutical companies.

AI in Pharmacovigilance Translation: What You Need to Know

Speed: Accelerating Turnaround Times

AI-powered translation can significantly reduce the time required to process pharmacovigilance documents. Advanced machine translation (MT) systems, supported by human oversight, can handle large volumes of text swiftly. This enables pharmaceutical companies to meet tight regulatory deadlines and ensures that adverse events (AEs) are reported and addressed promptly, safeguarding patient health.

Cost-Effectiveness: Reducing Translation Expenses

Traditional translation methods can be costly, especially when dealing with specialized medical terminology across multiple languages. AI solutions can process translations more cost-effectively by eliminating the need for redundant manual efforts. Companies can achieve up to 5x savings compared to traditional methods, as AI handles bulk translations efficiently without compromising quality.

Efficiency: Streamlining Workflows

AI accelerates translation and optimizes various PV processes. Automated systems can handle routine tasks such as data entry, template-building, and file conversion, freeing human resources for more critical activities. This enhanced efficiency allows PV teams to focus on higher-value tasks, improving overall productivity.

Accuracy: Ensuring High-Quality Translations

AI-powered MT engines can be trained on specific medical glossaries and regulatory materials, ensuring that translations are accurate and compliant with industry standards. By combining AI with expert human oversight, pharmaceutical companies can ensure that translations are precise, reducing the risk of miscommunication and errors in PV reporting.

Scalability: Handling Large Volumes with Ease

AI solutions offer unparalleled scalability, allowing companies to manage vast quantities of pharmacovigilance reports across multiple languages and regions. Unlike human-only teams, AI-powered engines can scale up or down as needed, providing flexible and reliable support for global operations without compromising quality or turnaround times (TAT).

Case Study: Find out how a Global Pharmaceutical Giant Scaled Up Translation with AI: 45,000+ words in 24 Hours

The Need

A leading global pharmaceutical company boasting over 100,000 employees across 90 countries faced an urgent challenge: they needed to deliver high volumes of pharmacovigilance translations with a guaranteed turnaround time of just 24 hours. Traditionally, their language services were sourced through local offices, resulting in a patchwork of diverse prices and processes. This fragmented approach was not only costly but also inefficient, especially with the requirement to translate thousands of highly technical pharmacovigilance documents swiftly and accurately.

The Solution

Beginning in southeast Asia and expanding globally, Welocalize established dedicated pharmacovigilance translation teams in key locations, including China, France, Mexico, and Vietnam. Additionally, Welocalize implemented a machine translation portal tailored to the company’s specific content, ensuring that translations were both precise and contextually accurate.

The Results

• Global Localization Network: The company now benefits from a seamless translation network that blends the expertise of human linguists with the efficiency of custom AI-powered MT.
• Remarkable Daily Output: They reliably achieve the translation of over 45,000 words within 24 hours, meeting stringent TAT requirements without compromising quality.
• Enhanced Consistency and Cost Efficiency: This innovative solution has resulted in faster turnaround times, greater translation consistency, and significant cost savings.
• Successful Expansion: Bolstered by Welocalize’s support, the company has successfully expanded its operations into several additional countries and is planning further growth into nine more European markets and several new languages.

By leveraging the combined power of AI and human expertise, this pharmaceutical giant has revolutionized its approach to pharmacovigilance translations, setting a new standard for efficiency and accuracy in the industry.

Embracing the Future of Pharmacovigilance Translation with AI

Integrating AI into pharmacovigilance translation processes marks a pivotal advancement for the pharmaceutical industry. By harnessing the power of AI, companies can achieve remarkable improvements in speed, efficiency, and cost-effectiveness, all while maintaining the highest standards of accuracy and compliance.

As the demand for rapid, high-quality pharmacovigilance translations continues to grow, partnering with an experienced AI-powered Language Service Provider (LSP) becomes increasingly essential. Such partnerships ensure companies can optimize their PV workflows, maintain regulatory compliance, and prioritize patient safety globally.

The future of pharmacovigilance translation lies in the intelligent fusion of AI and human expertise. Embracing this innovative approach empowers pharmaceutical companies to meet the challenges of a globalized world, delivering timely and accurate translations that uphold the highest standards of safety and efficacy. The time to leverage AI in pharmacovigilance translation is now—transform your operations and unlock new levels of success.